Actively Recruiting
Establishment of NAFLD Cohort and Development of Fibrosis Markers
Led by Seoul National University Boramae Hospital · Updated on 2025-05-15
1000
Participants Needed
1
Research Sites
886 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study is designed for establishment of non-alcoholic fatty liver disease patients cohort to development of markers to predict histologic progression of liver fibrosis.
CONDITIONS
Official Title
Establishment of NAFLD Cohort and Development of Fibrosis Markers
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with histologically confirmed fatty liver disease
- Patients with radiologically confirmed fatty liver disease
You will not qualify if you...
- History of significant alcohol consumption
- Viral hepatitis
- Autoimmune hepatitis
- Metabolic diseases such as hemochromatosis, M. Wilson, or alpha 1-antitrypsin deficiency
- Use of hepatotoxic medication such as amiodarone
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Seoul Metropolitan Government Seoul National University
Seoul, South Korea, 156-707
Actively Recruiting
Research Team
W
Won Kim, MD,PhD
CONTACT
S
Saekyung Joo, MD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here